Physician

Adam Jacob Kreitenberg, M.D.

According to 2025 Medicare claims, Adam Kreitenberg, M.D. (NPI: 1770857682) practices rheumatology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is BORIS D RATINER, MD, INC (NPI: 1700999117; TIN: 954853037) and primary practice location at 91356-4219.

Kreitenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 942 traditional Medicare patients, billed 129,079 HCPCS/CPT codes, and received $2,129,984 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,319 prescription claims across 393 beneficiaries totaling $2,631,061 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 47 claims. Open Payments data shows 529 records totaling $176,477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $120,131 to $2,129,984. Similarly, Part D prescription costs have risen steadily, from $79,588 to $2,631,061. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	297	3,367	$120,131
2016	645	19,497	$545,167
2017	704	29,106	$670,301
2018	751	41,891	$779,327
2019	674	54,868	$874,744
2020	734	45,955	$1,061,621
2021	799	65,338	$1,262,298
2022	831	76,341	$1,493,413
2023	883	85,712	$1,667,846
2024	942	129,079	$2,129,984

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	423	$79,588
2016	266	1,689	$561,841
2017	336	2,345	$925,219
2018	347	2,623	$1,344,711
2019	331	2,483	$1,559,062
2020	345	2,632	$1,607,929
2021	347	2,488	$1,790,242
2022	352	2,377	$2,145,702
2023	382	2,428	$2,343,187
2024	393	2,319	$2,631,061

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	38	45	$2,010
2017	22	36	$1,529
2018	26	31	$2,043
2019	19	21	$3,631
2020	13	14	$2,660
2021	13	14	$2,676
2022	23	43	$10,610
2023	31	51	$12,380
2024	29	47	$12,620

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	688	2,296	$114
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	487	2,239	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	564	1,337	$14
36415	Insertion of needle into vein for collection of blood sample	443	686	$9
82565	Blood creatinine level	332	476	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	50	1,568	$482,841
Orencia	Abatacept/Maltose	43	1,745	$250,335
Remicade	Infliximab	44	1,745	$218,096
Tremfya	Guselkumab	14	672	$188,357
Tymlos	Abaloparatide	64	1,920	$164,822

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	17	$6,065
L3807	Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	N	17	17	$4,508
L1820	Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	N	12	13	$2,047

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	529	$176,477	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Jacob Kreitenberg, M.D.?

Tedicare shows public-source Medicare data for Adam Jacob Kreitenberg, M.D. (NPI 1770857682), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Jacob Kreitenberg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Jacob Kreitenberg, M.D.?

Adam Jacob Kreitenberg, M.D. is linked to BORIS D RATINER, MD, INC (billing NPI 1700999117) in the available physician profile data.

Does Adam Jacob Kreitenberg, M.D. have Open Payments data?

Adam Jacob Kreitenberg, M.D. has 529 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.